MEDIFAST INC — Director's Dealing 2021

Jun 7, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2021-06-03

Reporting Person: Xian Ming (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-03	Restricted Stock Units (cash settled)	$	A	630	Acquired		Common Stock (630)	Direct

Footnotes

F1: Represents the right to receive 630 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Directors' Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 3, 2022. Each restricted stock unit represents a contingent right to receive the cash equivalent of one share of the Issuer's common stock.